{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:24:01Z","timestamp":1790828641385,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.japh.2021.07.007","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T12:41:40Z","timestamp":1626352900000},"page":"829-837.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Using group-based trajectory modeling to characterize the association of past ACEIs\/ARBs adherence with subsequent statin adherence patterns among new statin users"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2776-5401","authenticated-orcid":false,"given":"Zahra","family":"Majd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8779-8523","authenticated-orcid":false,"given":"Susan M.","family":"Abughosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.japh.2021.07.007_bib1","first-page":"63","article-title":"A\u00a0pharmacist telephone intervention to identify adherence barriers and improve adherence among nonadherent patients with comorbid hypertension and diabetes in a medicare advantage plan","volume":"22","author":"Abughosh","year":"2016","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"9 Suppl","key":"10.1016\/j.japh.2021.07.007_bib2","first-page":"S139","article-title":"Epidemiology and management of hyperlipidemia","volume":"23","author":"Karr","year":"2017","journal-title":"Am J Manag Care"},{"issue":"25","key":"10.1016\/j.japh.2021.07.007_bib3","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/CIRCULATIONAHA.119.041974","article-title":"Cost-related medication nonadherence in adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2017","volume":"140","author":"Khera","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.japh.2021.07.007_bib4","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.6004\/jnccn.2017.0168","article-title":"Nonadherence to statins and antihypertensives and hospitalizations among elderly Medicare beneficiaries with incident cancer","volume":"15","author":"Chopra","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"38","key":"10.1016\/j.japh.2021.07.007_bib5","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","author":"Chowdhury","year":"2013","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.japh.2021.07.007_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2016.06.005","article-title":"Assessing the impact of medication adherence on long-term cardiovascular outcomes","volume":"68","author":"Bansilal","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"46","key":"10.1016\/j.japh.2021.07.007_bib7","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1093\/eurheartj\/ehu364","article-title":"Non-adherence to cardiovascular medications","volume":"35","author":"Kolandaivelu","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.japh.2021.07.007_bib8","doi-asserted-by":"crossref","first-page":"E151","DOI":"10.5888\/pcd17.200244","article-title":"Cost-related nonadherence and mortality in patients with chronic disease: a multiyear investigation, national health interview survey, 2000\u20132014","volume":"17","author":"Van Alsten","year":"2020","journal-title":"Prev Chronic Dis"},{"issue":"10","key":"10.1016\/j.japh.2021.07.007_bib9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archinternmed.2011.32","article-title":"Effects of benefits and harms on older persons\u2019 willingness to take medication for primary cardiovascular prevention","volume":"171","author":"Fried","year":"2011","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.japh.2021.07.007_bib13","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.japh.2021.07.007_bib14","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2021.5469","article-title":"The leading causes of death in the US for 2020","volume":"325","author":"Ahmad","year":"2021","journal-title":"JAMA"},{"issue":"35","key":"10.1016\/j.japh.2021.07.007_bib16","doi-asserted-by":"crossref","first-page":"974","DOI":"10.15585\/mmwr.mm6735a3","article-title":"Vital signs: state-level variation in nonfatal and fatal cardiovascular events targeted for prevention by Million Hearts 2022","volume":"67","author":"Ritchey","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.japh.2021.07.007_bib18","author":"Saeed"},{"issue":"5","key":"10.1016\/j.japh.2021.07.007_bib19","first-page":"549","article-title":"A\u00a0motivational interviewing intervention by pharmacy students to improve medication adherence","volume":"23","author":"Abughosh","year":"2017","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"8","key":"10.1016\/j.japh.2021.07.007_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.CIR.0000139857.85424.45","article-title":"Should angiotensin II receptor blockers and statins be combined?","volume":"110","author":"Nickenig","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.japh.2021.07.007_bib21","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","article-title":"Adherence in hypertension","volume":"124","author":"Burnier","year":"2019","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.japh.2021.07.007_bib22","volume":"3","author":"Lee","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.japh.2021.07.007_bib24","first-page":"202","article-title":"Group-based trajectory models to identify sociodemographic and clinical predictors of adherence patterns to statin therapy among older adults","volume":"12","author":"Vadhariya","year":"2019","journal-title":"Am Health Drug Benefits"},{"issue":"10","key":"10.1016\/j.japh.2021.07.007_bib25","first-page":"1053","article-title":"Enhancing statin adherence using a motivational interviewing intervention and past adherence trajectories in patients with suboptimal adherence","volume":"25","author":"Abughosh","year":"2019","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"9","key":"10.1016\/j.japh.2021.07.007_bib26","first-page":"e537","article-title":"Predicting adherence trajectory using initial patterns of medication filling","volume":"21","author":"Franklin","year":"2015","journal-title":"Am J Manag Care"},{"issue":"2\u20133","key":"10.1016\/j.japh.2021.07.007_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000360229","article-title":"Group-based trajectory modeling: an overview","volume":"65","author":"Nagin","year":"2014","journal-title":"Ann Nutr Metab"},{"issue":"9","key":"10.1016\/j.japh.2021.07.007_bib28","first-page":"1138","article-title":"Medication adherence trajectories: a systematic literature review","volume":"26","author":"Alhazami","year":"2020","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"10","key":"10.1016\/j.japh.2021.07.007_bib29","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/ajh\/hpx086","article-title":"Antihypertensive adherence trajectories among older adults in the first year after initiation of therapy","volume":"30","author":"Hargrove","year":"2017","journal-title":"Am J Hypertens"},{"issue":"9","key":"10.1016\/j.japh.2021.07.007_bib30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s11606-016-3747-6","article-title":"Trajectories of diabetes medication adherence and hospitalization risk: a retrospective cohort study in a large state Medicaid program","volume":"31","author":"Lo-Ciganic","year":"2016","journal-title":"J\u00a0Gen Intern Med"},{"issue":"8","key":"10.1016\/j.japh.2021.07.007_bib31","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/pds.4012","article-title":"The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer","volume":"25","author":"Winn","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"10.1016\/j.japh.2021.07.007_bib32","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/pds.3787","article-title":"Association between trajectories of statin adherence and subsequent cardiovascular events","volume":"24","author":"Franklin","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.japh.2021.07.007_bib33","author":"Arrandale"},{"issue":"1","key":"10.1016\/j.japh.2021.07.007_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"issue":"9","key":"10.1016\/j.japh.2021.07.007_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MLR.0b013e3182984c1f","article-title":"Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence [published correction appears in Med Care. 2013;51(11):1029]","volume":"51","author":"Franklin","year":"2013","journal-title":"Med Care"},{"key":"10.1016\/j.japh.2021.07.007_bib36","first-page":"Doc11","article-title":"Re-revisiting Andersen\u2019s behavioral model of health services use: a systematic review of studies from 1998\u20132011","volume":"9","author":"Babitsch","year":"2012","journal-title":"Psychosoc Med"},{"issue":"6","key":"10.1016\/j.japh.2021.07.007_bib37","first-page":"678","article-title":"Medication adherence to antihypertensive triple-combination therapy among patients enrolled in a medicare advantage plan","volume":"25","author":"Wang","year":"2019","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"5","key":"10.1016\/j.japh.2021.07.007_bib38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jalz.2011.05.2414","article-title":"Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus","volume":"8","author":"Johnson","year":"2012","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.japh.2021.07.007_bib39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/gps.2604","article-title":"Risk factors for dementia in patients over 65 with diabetes","volume":"26","author":"Parikh","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.japh.2021.07.007_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ahj.2017.09.019","article-title":"The relative benefits of claims and electronic health record data for predicting medication adherence trajectory","volume":"197","author":"Franklin","year":"2018","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.japh.2021.07.007_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12877-019-1058-6","article-title":"Patterns of antihypertensive and statin adherence prior to dementia: findings from the adult changes in thought study","volume":"19","author":"Marcum","year":"2019","journal-title":"BMC Geriatr"},{"issue":"8","key":"10.1016\/j.japh.2021.07.007_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161381","article-title":"Medication adherence patterns after hospitalization for coronary heart disease. A population-based study using electronic records and group-based trajectory models","volume":"11","author":"Librero","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.japh.2021.07.007_bib43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/pds.4917","article-title":"Opening the black box of the group-based trajectory modeling process to analyze medication adherence patterns: an example using real-world statin adherence data","volume":"29","author":"Hickson","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.japh.2021.07.007_bib44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCOUTCOMES.116.002728","article-title":"Socioeconomic inequalities in statin adherence under universal coverage: does sex matter?","volume":"9","author":"Aarnio","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"10.1016\/j.japh.2021.07.007_bib45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/gerona\/glx169","article-title":"Adherence and persistence among statin users aged 65 years and over: a systematic review and meta-analysis","volume":"73","author":"Ofori-Asenso","year":"2018","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.japh.2021.07.007_bib46","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/PPA.S270809","article-title":"Group-based trajectory modeling to identify patterns of adherence and its predictors among older adults on angiotensin-converting enzyme inhibitors (ACEIs)\/angiotensin receptor blockers (ARBs)","volume":"14","author":"Paranjpe","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.japh.2021.07.007_bib47","series-title":"Adherence to Long-Term Therapies: Evidence for Action","author":"Sabat\u00e9","year":"2003"},{"issue":"3","key":"10.1016\/j.japh.2021.07.007_bib48","first-page":"e197","article-title":"Factors affecting medication adherence trajectories for patients with heart failure","volume":"21","author":"Juarez","year":"2015","journal-title":"Am J Manag Care"},{"issue":"2","key":"10.1016\/j.japh.2021.07.007_bib49","first-page":"186","article-title":"Identifying adherent patients to newly initiated statins using previous adherence to chronic medications","volume":"27","author":"Majd","year":"2021","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"6","key":"10.1016\/j.japh.2021.07.007_bib50","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.amjcard.2014.06.009","article-title":"Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event","volume":"114","author":"Muntner","year":"2014","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.japh.2021.07.007_bib51","first-page":"1146","article-title":"Using previous medication adherence to predict future adherence","volume":"24","author":"Kumamaru","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"4","key":"10.1016\/j.japh.2021.07.007_bib52","first-page":"494","article-title":"Predicting 1-year statin adherence among prevalent users: a retrospective cohort study","volume":"23","author":"Krumme","year":"2017","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"2","key":"10.1016\/j.japh.2021.07.007_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1017\/S1352465809005128","article-title":"Ten things that motivational interviewing is not","volume":"37","author":"Miller","year":"2009","journal-title":"Behav Cogn Psychother"},{"issue":"5","key":"10.1016\/j.japh.2021.07.007_bib54","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/dom.12195","article-title":"The potential for motivational interviewing to improve outcomes in the management of diabetes and obesity in paediatric and adult populations: a clinical review","volume":"16","author":"Christie","year":"2014","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.japh.2021.07.007_bib55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10884600590917174","article-title":"The transtheoretical model as a framework for developing substance abuse interventions","volume":"16","author":"Velasquez","year":"2005","journal-title":"J\u00a0Addict Nurs"},{"issue":"10","key":"10.1016\/j.japh.2021.07.007_bib56","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/ajh.2008.240","article-title":"A\u00a0practice-based trial of motivational interviewing and adherence in hypertensive African Americans","volume":"21","author":"Ogedegbe","year":"2008","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.japh.2021.07.007_bib57","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1001\/archpediatrics.2011.1","article-title":"Randomized controlled trial to improve care for urban children with asthma: results of the school-based asthma therapy trial","volume":"165","author":"Halterman","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"10.1016\/j.japh.2021.07.007_bib58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/09540120701593489","article-title":"Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study","volume":"20","author":"DiIorio","year":"2008","journal-title":"AIDS Care"},{"issue":"5","key":"10.1016\/j.japh.2021.07.007_bib59","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jaci.2007.08.017","article-title":"Brief motivational interviewing as a clinical strategy to promote asthma medication adherence","volume":"120","author":"Borrelli","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.japh.2021.07.007_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pedhc.2006.05.002","article-title":"Motivational interviewing: improving patient education","volume":"21","author":"Gance-Cleveland","year":"2007","journal-title":"J\u00a0Pediatr Health Care"},{"issue":"1","key":"10.1016\/j.japh.2021.07.007_bib61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.japh.2020.09.002","article-title":"Patient-reported barriers to statin adherence: excerpts from a motivational interviewing intervention in older adults","volume":"61","author":"Vadhariya","year":"2021","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2021.07.007_bib62","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1186\/s12913-014-0665-3","article-title":"Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement","volume":"14","author":"Yala","year":"2014","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.japh.2021.07.007_bib63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2261-11-46","article-title":"Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study","volume":"11","author":"Latry","year":"2011","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"10.1016\/j.japh.2021.07.007_bib64","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.amjcard.2011.01.052","article-title":"Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations","volume":"107","author":"Pittman","year":"2011","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.japh.2021.07.007_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242424","article-title":"Statin adherence is lower in primary than secondary prevention: a national follow-up study of new users","volume":"15","author":"Sigglekow","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.japh.2021.07.007_bib66","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1525-1497.2004.30516.x","article-title":"Suboptimal statin adherence and discontinuation in primary and secondary prevention populations","volume":"19","author":"Ellis","year":"2004","journal-title":"J\u00a0Gen Intern Med"},{"issue":"10","key":"10.1016\/j.japh.2021.07.007_bib67","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archinte.165.10.1147","article-title":"Predictors of adherence with antihypertensive and lipid-lowering therapy","volume":"165","author":"Chapman","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.japh.2021.07.007_bib68","doi-asserted-by":"crossref","first-page":"i3305","DOI":"10.1136\/bmj.i3305","article-title":"Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database","volume":"353","author":"Vinogradova","year":"2016","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.japh.2021.07.007_bib69","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1345\/aph.1P150","article-title":"Predictors of nonadherence to statins: a systematic review and meta-analysis","volume":"44","author":"Mann","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.japh.2021.07.007_bib70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ahj.2005.02.038","article-title":"Long-term adherence with cardiovascular drug regimens","volume":"151","author":"Kulkarni","year":"2006","journal-title":"Am Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2021.07.007_bib71","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0895-4356(01)00457-7","article-title":"Treatment adherence in chronic disease","volume":"54","author":"Dunbar-Jacob","year":"2001","journal-title":"J\u00a0Clin Epidemiol"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121003083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121003083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:50:23Z","timestamp":1761544223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319121003083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1544319121003083"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2021.07.007","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using group-based trajectory modeling to characterize the association of past ACEIs\/ARBs adherence with subsequent statin adherence patterns among new statin users","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2021.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}